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cohort of Patients with Transient 
ischemic attack: application  
of standard Vendor Protocols  
for lesion Detection and Final  
infarct size Projection
Inger Havsteen1*, Christian Ovesen 2, Lasse Willer 2, Janus Damm Nybing1, Karen Ægidius 2, 
Jacob Marstrand 2, Per Meden2, Sverre Rosenbaum2, Marie Norsker Folke 2,  
Hanne Christensen 2 and Anders Christensen1
1 Department of Radiology, Bispebjerg Hospital, Copenhagen University Hospital, Copenhagen, Denmark, 2 Department of 
Neurology, Bispebjerg Hospital, Copenhagen University Hospital, Copenhagen, Denmark
Objective: Diffusion tensor imaging may aid brain ischemia assessment but is more 
time consuming than conventional diffusion-weighted imaging (DWI). We compared 
3-gradient direction DWI (3DWI) and 20-gradient direction DWI (20DWI) standard vendor 
protocols in a hospital-based prospective cohort of patients with transient ischemic 
attack (TIA) for lesion detection, lesion brightness, predictability of persisting infarction, 
and final infarct size.
Methods: We performed 3T-magnetic resonance imaging including diffusion and 
T2-fluid attenuated inversion recovery (FLAIR) within 72  h and 8  weeks after ictus. 
Qualitative lesion brightness was assessed by visual inspection. We measured lesion 
area and brightness with manual regions of interest and compared with homologous 
normal tissue.
results: 117 patients with clinical TIA showed 78 DWI lesions. 2 lesions showed only on 
3DWI. No lesions were uniquely 20DWI positive. 3DWI was visually brightest for 34 lesions. 
12 lesions were brightest on 20DWI. The median 3DWI lesion area was larger for lesions 
equally bright, or brightest on 20DWI [median (IQR) 39 (18–95) versus 18 (10–34) mm2, 
P =  0.007]. 3DWI showed highest measured relative lesion signal intensity [median 
(IQR) 0.77 (0.48–1.17) versus 0.58 (0.34–0.81), P = 0.0006]. 3DWI relative lesion signal 
intensity was not correlated to absolute signal intensity, but 20DWI performed less well 
for low-contrast lesions. 3DWI lesion size was an independent predictor of persistent 
infarction. 3-gradient direction apparent diffusion coefficient areas were closest to 
8-week FLAIR infarct size.
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conclusion: 3DWI detected more lesions and had higher relative lesion SI than 20DWI. 
20DWI appeared blurred and did not add information.
clinical Trial registration: http://www.clinicaltrials.gov. Unique Identifier NCT01531946.
Keywords: transient ischemic attack, diffusion-weighted imaging, diffusion tensor imaging, infarction, magnetic 
resonance imaging
of critical motion artifacts (32, 33). Motion artifact rates rise 
with pathology presence (34), and in inpatient and emergency 
department settings (35). Hence, the best trade-off remains to be 
investigated in a clinical setting. We hypothesized that 20DWI 
would show equal or better ischemia detection and characteriza-
tion for small lesions, than standard 3DWI. We aimed to compare 
fast standard vendor protocols for conventional 3DWI with 
20-gradient direction DWI (20DWI), concerning lesion detection 
and characterization in subacute patients with TIA in a clinical 
setting. Specifically we compared 3- and 20DWI sequences for 
initial DWI lesion detection, measured and qualitative lesion 
brightness, and their ability to predict lasting infarction 8 weeks 
after ictus.
MaTerials anD MeThODs
We investigated a prospective patient cohort with clinical TIA 
included February 2012–December 2014. The study was approved 
by the National Committee of Biomedical Research Ethics (H-1-
2011-75, ClinicalTrials.gov Identifier NCT01531946). Patients 
were included after informed consent, in accordance with the 
Declaration of Helsinki.
Population and Procedures
On admission, a senior consultant stroke neurologist clinically 
evaluated the patients. We defined TIA as focal neurological 
deficit with resolution (National Institutes of Health Stroke Scale 
0) within 24 h, attributed to a vascular ischemic incidence.
Exclusion criteria were contraindications to MRI, non-TIA 
diagnosis, herein exclusion of patients treated with thrombolytics, 
and severe comorbidity likely to precluding follow-up. Included 
patients received MRI at two time points: routine brain ischemia 
imaging supplemented with 20DWI within 72 h, and at 8-week 
follow-up standard 3DWI and T2-fluid attenuated inversion 
recovery (FLAIR) to assess for new lesions.
We recorded symptoms, symptom duration, vascular risk fac-
tors, and ABCD2 and anamnestic factors including prior stroke, 
TIA or myocardial infarction (MI), angina pectoris, peripheral 
arterial disease, diabetes, or depression. We defined hyperten-
sion as preadmission use of antihypertensive medication, or 
hypertension diagnosis in the outpatient clinic. Atrial fibrillation 
was identified through medical history, admission 12-lead ECG, 
in-hospital telemetry (24–48 h) or subsequent outpatient cardiac 
follow-up. Hypercholestrolemia was total plasma cholesterol over 
5.0 mmol/L or statin treatment. Medical history or HbA1c > 6.5% 
defined diabetes. Smoking was present or prior smoking, and 
alcohol overuse was weekly alcohol intake over 252 g for males 
and 168 g for females. First degree relative with stroke or MI were 
recorded as hereditary risk factors.
Abbreviations: 3DWI, 3-gradient direction diffusion-weighted imaging; 20DWI, 
20-gradient direction diffusion-weighted imaging; ADC, apparent diffusion coef-
ficient; DTI, diffusion tensor imaging; DWI, diffusion-weighted imaging; FLAIR, 
fluid attenuated inversion recovery; FOV, field of view; IQR, interquartile range; 
MRI, magnetic resonance imaging; SI, signal intensity; SNR, signal-to-noise ratio; 
TE, echo time; TIA, transient ischemic attack; TR, repetition time; TSI, transitory 
symptoms with infarction.
inTrODUcTiOn
The risk of recurrent stroke after transient ischemic attack (TIA) 
is considerable (1), and clinical scores, as the ABCD2, have been 
validated and implemented in the guidelines (2). Recently, scores 
combining the clinical findings with diffusion-weighted imaging 
(DWI) lesion presence on magnetic resonance imaging (MRI), as, 
e.g., the ABCD3-I score, have been shown to improve subsequent 
stroke risk estimates in TIA patients (3–5).
Among patients with a clinical TIA diagnosis, DWI lesions 
are reported in 25–50% (4, 6–11), but an unexplained sevenfold 
variation in DWI positivity exists in literature (12). Rates are 
halved in populations with high stroke awareness, and easy-access 
high-volume TIA clinics (13). Large studies report lower rates 
compared with small studies, and time from ictus may influence 
the numbers underlining the instability of DWI positivity (12, 14).
Fast 3-gradient direction DWI (3DWI) shows acute ischemic 
lesions few minutes after ictus (15), and final lesion size is con-
sidered stationary after 7–30 days (16, 17). DWI lesions are het-
erogeneous, possibly as sign of varying degree of tissue damage, 
location, and recovery after reperfusion (18–20). This influences 
the subsequent extent of infarction on follow-up examinations 
(21). Diffusion tensor imaging (DTI) uses an increased number 
of diffusion encoding gradient directions and may depict brain 
microarchitecture including complex white matter tracts cross-
ings even on subvoxel level (22). Despite postprocessing chal-
lenges, the technique is robust (23) and is widely used clinically 
(24, 25). The more time-consuming DTI has been reported to be 
of value in assessing the presence and degree of brain ischemia in 
acute stroke and TIA (26–29) and aids the identification of small 
and low-contrast lesions, even beyond the capability of standard 
3DWI (30). DTI may be able to provide more homogeneous 
ischemia detection in the subacute phase, possibly with better 
correlation to the extent of the final lesion, and may thus help to 
better define patients with transitory symptoms with infarction 
(TSI) (31). We hypothesized that higher numbers of diffusion 
encoding gradients could add to qualitative lesion identification 
and delineation in a clinical setting.
However, any MRI protocol investigating acute or subacute 
brain ischemia must balance the diagnostic gain from longer 
sequences with scan time limits dictated primarily by the presence 
FigUre 1 | Regions of interest measurements. Co-registration method for 
lesion size and signal intensity on 3-gradient direction DWI.
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Upon arrival, patients underwent non-contrast head computed 
tomography and standard medical treatment, that is, admission 
to a specialized stroke ward, acute administration of two platelet-
inhibiting agents, and 24 h of electrocardiography observation. 
After the acute treatment, standard post-TIA workup included 
subacute MRI, risk-factor modification, and carotid ultrasound. 
CT-angiography or transcranial Doppler was not part of the 
protocol.
image acquisition
We performed 3T-MRI (Siemens Magnetom Verio, Siemens, 
Erlangen, Germany) with a 32-channel head coil (Siemens, 
Erlangen, Germany).
3-Gradient direction DWI was Siemens’ single-shot spin-
echo diffusion echo-planar imaging protocol with 220-mm field 
of view (FOV), 25 4-mm axial 0-mm gap slices, b-values 0 and 
1,000 s/mm2 along 3 orthogonal directions; repetition time (TR)/
echo time (TE) 6,600/100 ms, acceleration factor R 2, in plane 
resolution for 3DWI and 3-gradient direction apparent diffusion 
coefficient (ADC) was 1.1 mm × 1.1 mm, 4 averages, bandwidth 
1,002 Hz/Px, and scan time 2:07 min:s.
20DWI was Siemens’ single-shot echo-planar imaging pro-
tocol with 230 mm FOV, 25 4-mm axial 0-mm gap slices, TR/
TE 3,600/95 ms, acceleration factor R 2, in plane resolution for 
20DWI and 20ADC was 1.8  mm ×  1.8  mm, b-values 0, and 
1,000 s/mm2, 3 averages, bandwidth 1,502 Hz/Px, and scan time 
4:39 min:s.
The T2-FLAIR protocol was 240-mm FOV, 27 4-mm axial 
0-mm gap slices, TR/TE 6,500/133 ms, TI 2,134 ms, acceleration 
factor R 2, in plane resolution 0.9 mm × 0.9 mm, and scan time 
3:32 min:s.
The 20DWI protocol’s scan parameters used, including the 
number of directions, the lower matrix size, and averages were 
vendor’s best compromise for acceptable image quality and 
scan time. Vendor’s noise reduction postprocessing algorithm 
in 3ADC and 20DWI and 20ADC nulls signal from air. Further 
details on postprocessing and their impact on signal intensity (SI) 
were not available. The baseline protocol also included perfusion 
sequences.
image interpretation
We performed the study in a clinical setting using the PACS 
only, without external software. One neuroradiologist (IH) sys-
tematically evaluated all scans according to a predefined chart. 
The radiologist was informed of side and nature of neurological 
symptoms through the PACS referral.
We co-registered lesions describing their positions with two 
perpendicular intrathecal diameters to ascertain lesion localiza-
tion between sequences and baseline, and 8-week MRI (Figure 1). 
DWI hyperintensities were compared with ADC, and initial 
T2-FLAIR images for ADC confirmation, and to avoid T2 shine 
through from chronic infarctions or leukoaraiosis. Two separate 
lesions should not have confluent gliosis. We defined 8-week 
infarction as presence of T2-hyperintensity, or atrophy in the area 
of initial DWI lesion at 8-week follow-up. After all radiological 
and clinical data were collected, we investigated if symptoms 
matched lesion site, under supervision of a senior stroke neurolo-
gist consultant (HC).
lesion size estimate
We defined lesion size as the largest lesion area measured by 
manual regions of interest (ROIs), delineating lesion periphery on 
a single slice in 3DWI, 3ADC, 20DWI, 20ADC, initial T2-FLAIR, 
and 8-week T2-FLAIR (30).
Qualitative lesion Brightness and 
Measured si Differences
We scored lesion brightness on 3- and 20DWI and assessed if 
a lesion was more distinct on either or equal, blinded to other 
findings (Figure 2).
We assessed lesions according to the “hot spot” method (36, 37). 
For lesions visible on both 3- and 20DWI, we measured lesion 
size and SI. We drew an ROI around the lesion’s area, and a second 
ROI covering a homologous area in the contralateral hemisphere, 
avoiding areas of chronic infarction, leukoaraiosis or cerebrospi-
nal fluid. We used manual ROIs (Figure 1).
For 3DWI and 20DWI sequences, we calculated a relative 
signal intensity (rSI) difference between ipsilateral (i) infarcted 
and contralateral (c) normal tissue: rSI = (SIi − SIc)/SIc. We com-
pared the sequences’ relative signal variation using medians and 
interquartile ranges (IQRs).
FigUre 2 | Qualitative lesion brightness on 3- and 20-gradient diffusion 
imaging. Diffusion-weighted imaging (DWI) lesion shows on 3-gradient DWI 
(3DWI) (a), 20-gradient DWI (B) shows no certain lesion, but blur. Panels 
(c,D) equal lesion brightness on 3DWI (c) and 20DWI (D). Panels (e,F) 
lesion brightest on 20DWI (F).
FigUre 3 | STROBE diagram of patient in- and exclusion. Other contained 
patients with peripheral nerve compression (2), ophthalmological symptoms 
(2), trigeminal neuralgy (1), normal pressure hydrocephalus (1), 
hyperventilation (1), paresthesia secondary to anemia (1), peripheral extremity 
embolus (1), food poisoning (1), and secondary refusal (1). Reasons for lack 
of 20DWI/apparent diffusion coefficient (ADC) were technician error (3), 
incomplete examination due to restless patient (1), and technical error (1).
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To compare sequences we calculated the sequences’ difference 
in relative signal intensity compared with the standard 3DWI’s 
relative signal intensity: %SI = 100*(rSI20 − rSI3)/rSI3 (30).
statistics
Data are shown as frequencies, medians with IQR, or odds ratio 
(OR) with 95% confidence intervals (95% CI) as appropriate. 
We compared categorical data using the Fisher’s exact test, and 
continuous and ordinal scale data using the Mann–Whitney 
U test. Proportions of repeated measurements were analyzed 
using McNemar’s test. Lesion area measurement on the different 
sequences was compared using the Bland–Altman technique and 
calculated the median deviation and the mean bias. We performed 
logistic regression analysis and used Wald test for P-values. We 
tested for correlations using Spearman’s rho. We considered 
P-values less than 0.05 significant. For statistical computation 
we used R (version 3.2.0), 2015 The R Foundation for Statistical 
Computing, Vienna, Austria—http://www.R-project.org/ and 
SPSS (version 22.0) statistical software, IBM Corporation, 
Armonk, NY, USA. In a 10% sample (patients born 4th, 14th, 
and 24th day in any month), we calculated Cohen’s kappa for 
intraobserver variation of qualitative data using two readings 
with 3  months’ interval, and found substantial intraobserver 
agreement (kappa 0.80).
resUlTs
Among 199 consenting and included patients, 64 patients were 
later excluded, due to final non-TIA diagnosis, according to treat-
ing stroke neurologist. Further 18 patients were excluded, due to 
unavailable 20DWI sequence, or as they declined the 8-week MRI 
(Figure 3). The final cohort contained 117 patients with TIA with 
149 clinical or radiological events. 46 patients showed 78 diffu-
sion lesions. Patient characteristics are presented in Table 1. The 
median (IQR) time from ictus to initial MRI was 32 (24–57) h.
We lost 18 patients for analysis (13%, 18/135). The five patients 
with no 20DWI/ADC were diffusion positive. Among the 13 
patients with no 8-week MRI, 5 patients were diffusion positive. 
TaBle 1 | Patient characteristics.
All patients 117
Female sex, n 51 (44%)
Age, median (IQR) 65 (55–71)
Medical history
Prior stroke 21 (18%)
Prior TIA 12 (10%)
Prior MI 8 (7%)
Atrial fibrillation 12 (10%)
Hypertension 56 (48%)
Diabetes 16 (14%)
Depression 12 (10%)
Current smoking 39 (34%)
Alcohol overuse 11 (10%)
Antiplatelet use 40 (34%)
Warfarin use 1 (1%)
index stroke
ABCD2, median (IQR) 4 (3–5)
Duration of symptoms (min)
<60 57 (49%)
>60 60 (51%)
TOAST etiology
Small vessels 47 (40%)
Large vessels 25 (21%)
Cardiogenic 18 (15%)
Multiple possible etiologies 27 (23%)
TTS (h) 32 (24–57)
TTF (days) 56 (55–60)
Numbers are frequency (%) unless otherwise indicated.
TIA, transient ischemic attack; MI, myocardial infarction; IQR, interquartile range; TTS, 
time to scan; TTF, time to follow-up.
TaBle 2 | Baseline lesion areas (cm2) for diffusion-weighted imaging (DWI)-positive lesions.
lesions 3-gradient direction DWi 20DWi* 3aDc 20aDc* T2-initial fluid attenuated 
inversion recovery (inFlair)
N, all 78 76 71 70 63
Range 0.03–5.88 0.05–5.38 0.03–5.07 0.03–5.31 0.05–6.03
Median [interquartile range (IQR)] 0.26 (0.11–0.59) 0.34 (0.19–0.79) 0.23 (0.14–0.60) 0.24 (0.12–0.63) 0.31 (0.15–0.80)
N, scar 50 (64%) 50 (66%) 49 (69%) 48 (69%) 50 (79%)
Range, scar 0.05–5.88 0.06–5.38 0.03–5.07 0.05–5.31 0.05–6.03
Range, no scar 0.03–1.10 0.05–1.05 0.03–2.17 0.03–1.55 0.04–1.56
Median (IQR), scar 0.41 (0.13–0.86) 0.53 (0.26–1.07) 0.34 (0.16–1.00) 0.38 (0.18–0.86) 0.37 (0.18–0.89)
Median (IQR), no scar 0.17 (0.08–0.22) 0.21 (0.10–0.27) 0.17 (0.07–0.23) 0.12 (0.08–0.18) 0.20 (0.08–0.89)
Pa P < 0.0001 P < 0.0001 P = 0.001 P < 0.0001 P < 0.0001
117 patients with 149 events completed 3- and 20DWI sequences and 8-week (8w) magnetic resonance imaging.
aMann–Whitney U test for 8-week scar versus no scar.
31 lesion appeared only on 8w-FLAIR (DWI negative), it is in these data but is probably an intercurrent lesion.
*20DWI/apparent diffusion coefficient (ADC) data were unavailable for 5 patients with 6 lesions.
In, initial.
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Thus, among the 135 patients with clinical TIA, 56 patients (41%) 
were diffusion positive. This proportion is not significantly differ-
ent from the group included for analysis (P = 0.71).
lesion Detection
On initial scan 78 (52%) lesions were 3- and 76 (51%) 20DWI 
positive (P =  0.500, Table  2). 51 (34%) lesions showed hyper-
intensity or atrophy on 8-week FLAIR. Hereof 50 lesions were 
initially DWI positive. One initially DWI-negative 8-week 
hyperintense FLAIR lesion was found in a patient with small 
vessel disease pattern, which may have been invisible early after 
reperfusion (14), or a silent intercurrent infarction.
Two lesions were only visible on 3DWI, they were small, 
measuring 0.03 and 0.11 cm2. Both lesions showed no ADC con-
firmation and no infarction on 8-week FLAIR. No lesions were 
uniquely 20DWI or -ADC positive.
lesion size
Lesions were slightly, non-significantly, smaller on 3DWI 
than 20DWI [median (IQR) 0.29 (0.11–0.72) cm2 versus 0.35 
(0.20–0.80) cm2, P = 0.26].
Qualitative lesion Brightness
Among events 3DWI was qualitatively most distinct in 34 
lesions (22%), 12 lesions (8%) were most conspicuous on 20DWI 
(Table 3). 32 lesions (22%) were equally conspicuous on 3- and 
20DWI. The median (IQR) 3DWI lesion area was larger for 
lesions brightest on 20DWI, or equally bright compared with 
3DWI-brightest lesions [39 (18–95) versus 18 (10–34) mm2, 
P = 0.007]. Among patients with diffusion lesions, the probability 
of persistent infarction was significantly higher for lesions equally 
positive or brightest on 20DWI, compared with lesions brightest 
on 3DWI (crude OR 3.83, 95% CI: 1.44–10.14). In general, the 
predictive value toward persistent infarction was the same for 
patients with lesions on 3DWI or 20DWI (Table 4). The negative 
predictive value (both 0.99) was high. The positive predictive 
values (0.64 and 0.66) were fair for both. The strongest positive 
predictive value for infarction was, if either the 20DWI lesion 
was most prominent, or if the lesion was equally bright on 3DWI 
and 20DWI (PPV 0.77). To investigate, if the association between 
lesions most bright on 20DWI (or equal to 3DWI) and persistent 
infarction signs was confounded by the size of the lesion, we 
adjusted for lesion areas measured on 3DWI. Lesion area size 
emerged as an independent predictor of lasting infarction, inde-
pendent of perceived brightness on any sequence, and perceived 
brightness lost its predictive capability. 20DWI lesions often 
appeared blurred (Figure 2), probably due to lower resolution.
FigUre 5 | Comparison of difference in relative signal intensity (%SI) to 
absolute signal intensities on 3-gradient direction DWI (3DWI)- and 20DWI, 
linear model regression lines with equations, N = 76. Difference in relative 
signal intensity is uniform for absolute 3DWI lesion signal intensities, but lower 
for low-signal lesions on 20DWI.
FigUre 4 | Comparison of relative lesion signal intensity (rSI) on 3-gradient 
direction DWI (3DWI) and 20DWI, N = 76. rSI is the normalized difference 
between signal intensities in lesions and contralateral homologous normal 
tissue, i, ipsilateral (lesion); c, contralateral. 3- and 20DWI sequences’ relative 
lesion signal intensity shows linear correlation. Best linear model fit has 0.7 
incline implying that 3DWI has 30% higher relative lesion signal intensity than 
20DWI. The dashed reference line has slope 1 indicating where rSI3 = rSI20.
TaBle 4 | Binary classification measures for lasting infarction for qualitatively 
most distinct sequence.
Most distinct sequence sensitivity specificity PPV nPV accuracy
3DWI lesion 0.98 0.71 0.64 0.99 0.52
20DWI lesion 0.98 0.73 0.66 0.99 0.70
3DWI brightest + equal 0.80 0.74 0.62 0.88 0.77
20DWI brightest + equal 0.67 0.90 0.77 0.84 0.82
Lesions appearing subjectively most distinct on either 3- direction DWI (3DWI) or 
20-gradient DWI (20DWI) sequence: sensitivity, specificity, positive (PPV) and negative 
predictive value (NPV), and accuracy for 8-week scarring in 149 lesions. 51 lesions 
show 8-week scar. Equal describes DWI-positive lesions that appear equally bright on 
3- and 20DWI.
TaBle 3 | Qualitative brightness and probability of 8-week infarction among 149 
clinical or radiological transient ischemic attack events.
Most distinct 
sequence
N (%) P of  
infarction (%)
crude Or adjusted Or
Brightest on 3DWI 34 (23) 47 1.00 1.00
Brightest on 20DWI 12 (8) 75 3. 38  
(0.78–14.68)
3.55  
(0.74–7.10)
Equally positive 32 (22) 78 4.02  
(1.37–11.77)
2.38  
(0.72–17.10)
Negative on both 71 (48) 1 – –
P of infarction is the probability of persistent infarction within each brightness category. 
Crude OR is the crude odds ratio for persistent infarction within diffusion-weighted 
imaging-positive lesions, reference category is lesions brightest on 3-gradient direction 
DWI (3DWI). Adjusted OR is the crude OR adjusted for 3DWI lesion size.
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lesion contrast as Measured si
The relative signal intensity on 3- and 20DWI was linearly cor-
related (Figure  4), and the relative lesion signal intensity was 
higher on 3DWI than 20DWI [median (IQR) 0.77 (0.48–1.17) 
versus 0.58 (0.34–0.81), P =  0.0006]. 20DWI’s median relative 
signal variation was systematically lower than 3DWI’s [median 
(IQR) rSI20/rSI3: 0.70 (0.59–0.84)].
The difference in relative signal intensity (%SI) was positively 
correlated to absolute 20DWI lesion SI (Figure  5, lower panel, 
Spearman’s rho = 0.28, P = 0.01). That is, 20DWI showed increased 
relative signal intensity on high-contrast lesions, and lower contrast 
for lesions with lower absolute SI. For 3DWI there was no correla-
tion between the difference in relative signal intensity (%SI) and 
absolute 3DWI lesion SI (Figure 5, upper panel, rho = −0.0088), nor 
relative 3DWI lesion signal intensity (rSI3, rho = −0.0837). Small 
lesions showed predominantly highest SI on 3DWI (Figure 6).
FigUre 6 | Distribution of lesions according to size measured on 3-gradient 
direction DWI (3DWI), and the two sequences’ difference in relative signal 
intensity (%SI), N = 76. The dashed reference line indicates where 
rSI3 = rSI20. Small lesions show highest variation in the two sequences’ 
difference in relative signal intensity (%SI), and predominantly highest relative 
signal intensity on 3DWI (i.e., %SI is negative).
FigUre 7 | Initial lesions’ median deviation from 8-week infarction area. This 
figure presents the median deviation between the initial lesion area on the 
respective sequences, and the area of the final infarction on 8-week 
magnetic resonance imaging. The smallest deviation (initial 3ADC) is 
significantly smaller than the deviation yielded by 3-gradient direction DWI 
(3DWI) or 20DWI. 20ADC and fluid attenuated inversion recovery (FLAIR) 
yielded deviations not significantly different from 3ADC.
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Final infarct size estimate
There was a significant difference between the different MRI 
sequences’ ability to estimate the size of the final infarct 
(P < 0.0001). Figure 7 shows that areas measured on subacute 
3ADC have lowest median (IQR) deviation compared with the 
final infarct size [7 (−2.5 to 26) mm2]. This was significantly lower 
than 3DWI (P = 0.011) and 20DWI (P < 0.001). However, no 
statistical difference was found between the median deviations on 
3ADC, 20ADC, and FLAIR. Complete Bland–Altman diagrams 
with mean bias are shown in Figure 8.
DiscUssiOn
This study compared fast standard vendor diffusion protocols 
for mild ischemia detection and characterization in clinical 
workflow. The faster 3DWI detected more lesions than 20DWI, 
and 20DWI lesions were often blurred. 3DWI had higher meas-
ured and perceived lesion SI. Neither perceived, nor measured 
lesion brightness was independently associated with persistent 
infarction, only lesion size. 3ADC in plane area gave the closest 
prediction of final infarct size, although not statistically better 
than 20ADC. 20DWI did not add clinically relevant information 
in a subacute population with TIA.
This study’s main limitations include the small size of TIA-
related lesions, lower 20DWI resolution and number of k-space 
averages. For T2-FLAIR low-contrast conditions, and gradual 
lesion SI increase over time, render quantitative measurements 
and interobserver study challenging. Challenging is also the sub-
acute time window where small lesions without ADC confirma-
tion, but beginning FLAIR-visibility, are difficult to differentiate 
from chronic lesions’ T2 shine-though. Therefore, we designed 
the study to be mainly dichotomous, denoting visible presence or 
absence of an ischemic lesion, and matched symptoms and lesion 
site. All patients underwent standardized imaging, and analysis 
was performed on specialist level, to ensure highest possible 
homogeneity. Our population was not consecutive, as inclusion 
was based on informed consent, and presumably showed a higher 
lesion rate than a consecutive cohort. A potential limitation is the 
lack of blinding between sequences, but this was not feasible, due 
to the need for certain lesion identification and comparison. Also, 
perfusion images were not analyzed in this context.
Clinical diagnosis of these small lesions is valuable, as their 
presence is correlated to increased morbidity and mortality 
(38). The previously reported improved lesion detection on a 
15-gradient direction DWI compared with 3-gradient DWI (30), 
used a 3DWI with lower in plane resolution compared with ours. 
The diversity in 3DWI sequences used, may explain part of the 
reported variation in TIA populations’ DWI-positivity rates.
Small lesion imaging combines the challenge of high resolu-
tion with short acquisition time to limit motion artifacts. Here, 
we used standard sequences with vendor’s best compromise for 
resolution. Measuring small lesions, relative to the achieved 
voxel resolution, one may encounter a relative large fractional 
measurement error, simply due to small size, and relatively 
large error margins for small lesions (volume <5 mL) have been 
reported (39).
The gradual FLAIR SI increase over time (37, 40) is a chal-
lenge, especially for small lesions. The interrater agreement 
was lower for FLAIR than DWI, in a study of DWI–FLAIR 
mismatch (40). While developed FLAIR high signal showed 
good interrater agreement, subtler changes showed only 
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FigUre 8 | Bland–Altman diagrams per initial sequence (a–e) comparing initial lesion size with 8-week infarct size.
moderate agreement (kappa 0.59) (37) and were challenging 
for clinicians (41). Addition of semiautomated lesion measure-
ment did not improve visual lesion assessment and interrater 
agreement (36).
The discrepancy between clear clinical stroke or TIA pres-
entation and diffusion-negativity has been widely reported (12, 
42), and the more advanced 20DWI sequence, used in this study, 
did not add further information. On the contrary, 3DWI found 
two more lesions than 20DWI. 20DWI was prone to blurring, 
presumably due to lower resolution and fewer k-space averages, 
and possibly intrinsic noise removing postprocessing, and 
3ADC area showed better correlation to the resulting infarction 
area. This study’s findings concur with reservations about TSI 
subgrouping of TIA patients, as opposed to those without initial 
DWI lesion. Thus, the best tools available seem to be clinical 
decision scores, which also take DWI-positivity into account, 
but still consider TIA patients as one common patient group, as, 
e.g., ABCD3-I.
This study ran under standardized conditions in a subacute 
clinical setting, focusing on optimizing high lesion detectability, 
acceptable scan time and standardized image interpretation 
after a predefined chart from the PACS alone, without external 
postprocessing software. It describes a clinical setting where 
the MRI findings must be both fast to interpret, and the MRI 
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